Gene Biotherapeutics, Inc.

Gene Biotherapeutics, Inc.verified

CRXM

Price:

$0.0001

Market Cap:

$6.49K

Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product candidate is Generx, an angiogenic gene therapy product candidate in Phase 3 clinical trials for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. It is also developing Generx for ischemia-related cardiovascular and cerebral therapeutic indications. Gene Biotherapeutics, Inc. has an agreement with Fujifilm Diosynth Biotechnologies for the manufacture of Generx angiogeni...[Read more]

Industry

Biotechnology

IPO Date

2000-05-03

Stock Exchange

OTC

Ticker

CRXM

The Dividend Yield as of November 2025 (TTM) for Gene Biotherapeutics, Inc. (CRXM) is 0%

According to Gene Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Gene Biotherapeutics, Inc. (CRXM) Historical Dividend Yield (quarterly & annually)

How has CRXM Dividend Yield performed in the past?

The mean historical Dividend Yield of Gene Biotherapeutics, Inc. over the last ten years is 3.85%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), CRXM's Dividend Yield was at its highest in in the March 2011 quarter at 0%. The Dividend Yield was at its lowest in in the March 2011 quarter at 0%.

Quarterly (TTM)
Annual

Average

3.85%

Median

0%

Minimum

0%

Maximum

38.53%

Gene Biotherapeutics, Inc. (CRXM) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Gene Biotherapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 38.53%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20200%0%
20190%0%
20180%0%
20170%-100.00%
201638.53%Infinity%
20150%0%
20140%0%
20130%0%
20120%0%
20110%0%

Gene Biotherapeutics, Inc. (CRXM) Average Dividend Yield

How has CRXM Dividend Yield performed in the past?

The current Dividend Yield of Gene Biotherapeutics, Inc. (CRXM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

7.71%

10-year avg

3.85%

Gene Biotherapeutics, Inc. (CRXM) Dividend Yield vs. Peers

How is CRXM’s Dividend Yield compared to its peers?

Gene Biotherapeutics, Inc.’s Dividend Yield is less than Gelesis Holdings, Inc. (0%), less than NeonMind Biosciences Inc. (0%), less than E-Qure Corp. (0%), less than GeneThera, Inc. (0%), less than American CryoStem Corporation (0%), less than Capha Pharmaceuticals Inc. (0%), less than Acacia Diversified Holdings, Inc. (0%), less than Generex Biotechnology Corporation (0%), less than Navidea Biopharmaceuticals, Inc. (0%), less than WPD Pharmaceuticals Inc. (0%),

Build a custom stock screener for Gene Biotherapeutics, Inc. (CRXM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gene Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gene Biotherapeutics, Inc. (CRXM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gene Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Gene Biotherapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Gene Biotherapeutics, Inc. (CRXM)?

What is the highest Dividend Yield for Gene Biotherapeutics, Inc. (CRXM)?

What is the 3-year average Dividend Yield for Gene Biotherapeutics, Inc. (CRXM)?

What is the 5-year average Dividend Yield for Gene Biotherapeutics, Inc. (CRXM)?

How does the current Dividend Yield for Gene Biotherapeutics, Inc. (CRXM) compare to its historical average?